Since 2023, the Health Bureau has implemented a comprehensive quality indicator framework for chronic disease management. The initiative initially targeted diabetes, expanded to hypertension in 2024, and this year includes dyslipidemia treatment. The program aims to boost patients’ “awareness, treatment, and control rates.”
Data for 2024 show that approximately 60 percent of diabetes patients have achieved blood glucose control, 71 percent have blood pressure under control, and 60 percent have reached target cholesterol levels. About 11,000 patients met all three health indicators — 3,600 more than the previous year. Hypertension control rates also improved, rising from 48 percent to 62 percent, with more than 11,000 patients showing better blood pressure management.
To address the growing patient load, the Health Bureau has introduced a medical “diversion system” by partnering with non-governmental organizations (NGOs) to support the management of stable chronic cases. The city has adopted a “standardized metabolic disease management center” model developed by the Shanghai Institute of Endocrinology, offering one-stop services. Patients can now undergo eye, foot nerve, and electrocardiogram (ECG) examinations in a single visit at NGO community clinics. The initiative integrates smart healthcare technologies and artificial intelligence to enhance diagnostic accuracy and patient experience.
Currently, the Women’s General Association of Macau is collaborating with the Tap Seac Health Center on diabetes management. Next year, cooperation will expand to the General Union of Neighborhood Associations, extending services to the Fai Chi Kei and Ilha Verde health centers.
According to the Health Bureau, the incidence rate of stroke among diabetes patients has been declining since 2019 and remains lower than that of neighboring regions, reflecting significant progress in chronic disease management. The Fai Chi Kei Health Center alone provided medical services to more than 38,000 diabetes patients last year.
